Skip to content

Clinical observation and analysis between varicella zoster virus load in acute stage of herpes zoster and the incidence of postherpetic neuralgia

Clinical observation and analysis between varicella zoster virus DNA load in acute stage of herpes zoster and the incidence of postherpetic neuralgia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025544
Enrollment
Unknown
Registered
2019-08-31
Start date
2019-12-11
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postherpetic neuraljia

Interventions

PHN:no
no-PHN:no

Sponsors

General Hospital of Eastern Theater Command, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. It meets the diagnostic criteria for herpes zoster in Chinese clinical dermatology edited by zhao bian. 2. Patients of herpes zoster with pain in acute stage were hospitalized without antiviral treatment before. 3. Aged over 18 years, male or female, estimated survival time is more than 3 months. 4. Antiviral (aciclovir or ganciclovir) treatment is required.

Exclusion criteria

Exclusion criteria: 1. Allergy to antiviral drugs (aciclovir and ganciclovir) . 2. Cannot follow the doctor's instructions to complete the treatment plan and visit plan. 3. Disagree to participate in the blood drawing test and follow-up of this study. 4. Patients with impaired consciousness and communication. 5. Patients with poor general conditions, unable to objectively describe symptoms and unable to actively cooperate. 6. Receive herpes zoster vaccination recently. 7. Accompanied by severe immune diseases, such as HIV. 8. Patients with severe shock. 9. Pregnant women.

Design outcomes

Primary

MeasureTime frame
varicella zoster virus DNA load;

Countries

China

Contacts

Public ContactJin Yi

General Hospital of Eastern Theater Command, PLA

kimye@vip.163.com025-80862066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026